#xs0432810116
1 story tagged "xs0432810116".
Advertise Here
Reach qualified buyersBoost your visibility among pharma sourcing professionals and potential buyers.
- Grow your business with qualified leads
- GDS reports on your ad performance
- Targeted to this product's audience
- Direct enquiries from buyers
- Visibility to pharma professionals
Novartis remibrutinib delivered comprehensive disease control in Phase III RMS trials, with proven, robust safety profile
Basel, October 23, 2026 – Novartis today presented positive results from the pivotal Phase III REMODEL-1 and REMODEL-2 trials in relapsing multiple sclerosis (RMS) showing that remibrutinib, a highly selective and…
Latest news
Showing 1–1 of 1 storiesAdvertise on PharmaJungle - Free for 30 Days
Get your company in front of buyers, manufacturers, and sourcing professionals on PharmaJungle - completely free for your first 30 days.
- 30 days of free advertising
- Visibility across all pages
- Performance report with ad insights
- No setup or registration fee
Exclusive introductory offer for new advertisers
Top sources
Post your requirement
Get offers from suppliers
- Reach pharmaceutical suppliers
- Specify quality standard and quantity
- Set your shipping preference
- Receive offers directly
- Listed on our marketplace
Your product details and requirements may be published on the marketplace.
Create a New Buying Request
Fields marked with * are mandatory.